Radiation Toxicity (Toxicology) Market pipeline report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Radiation Toxicity Pipeline market report is complete research and development history and latest news and press releases. The report provides an overview of the Radiation Toxicity (Toxicology) pipeline landscape
Complete report on www.reportsnreports.com/reports…paign=Paid .
Radiation Toxicity (also known as radiation sickness) is an acute illness caused by irradiation of the entire body by a high dose of penetrating radiation in a very short period of time (usually a matter of minutes). The major cause of this syndrome is depletion of immature parenchymal stem cells in specific tissues.
Symptoms include bleeding from the nose, mouth, gums, and rectum, bloody stool, bruising, confusion, dehydration, diarrhea, fainting and fatigue.Access this Report at www.reportsnreports.com/contacts/992882
The Radiation Toxicity market (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 3, 5, 7, 46, 9 and 1 respectively.
Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 4 and 1 molecules, respectively.
Report: www.reportsnreports.com/contacts/992882
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Companies Involved in Therapeutics Development
Aeolus Pharmaceuticals Inc, Angion Biomedica Corp, Atox Bio Ltd, BCN Biosciences LLC, Bolder Biotechnology Inc, Cellerant Therapeutics Inc, Cellphire Inc, Chrysalis BioTherapeutics Inc,Cleveland BioLabs Inc, Daiichi Sankyo Company Ltd, FirstString Research Inc, Foresee Pharmaceuticals LLC, Galera Therapeutics Inc, Genzyme Corp, GNI Group Ltd,Humanetics Corp,Insys Therapeutics Inc, Meabco A/S,Neumedicines Inc, Nohla Therapeutics Inc, Onconova Therapeutics Inc, Original BioMedicals Co Ltd, PharmaIN Corp, Pluristem Therapeutics Inc,RDD Pharma Ltd, Reata Pharmaceuticals Inc, RedHill Biopharma Ltd, RxBio Inc, Shuttle Pharmaceuticals LLC,SK Chemicals Co Ltd, Soligenix Inc, Synedgen Inc, Tonix Pharmaceuticals Holding Corp, TSRL Inc, viDA Therapeutics Inc, Windtree Therapeutics Inc.
List of Figures
Number of Products under Development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Top 10 Routes of Administration, H1 2017
Number of Products by Stage and Top 10 Routes of Administration, H1 2017
Number of Products by Top 10 Molecule Types, H1 2017
Number of Products by Stage and Top 10 Molecule Types, H1 2017.
News From
ReportsnReports Category: Industry Reports & Market Analysis Profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets. Email us at This email address is being protected from spambots. You need JavaScript enabled to view it..
